CellCentric vs Laverock Therapeutics
CellCentric vs Laverock Therapeutics, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: CellCentric is on 60/100 and Laverock Therapeutics on 41/100.
Where each one leads
CellCentric
- our overall score: 60/100 against 41/100
- domain rating: 35/100 against 21/100
- funding raised: $375M against $10.0M
Laverock Therapeutics
Leads on none of the measures we hold for both companies.
At a glance
| Measure | CellCentric | Laverock Therapeutics |
|---|---|---|
| What it is | A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma. | Developing disease-responsive advanced therapies through programmable gene control technology. |
| Category | Biotechnology, Pharmaceuticals, Healthcare, Biotech | Biotechnology, Gene Therapy, Drug Delivery, Healthcare |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Platform |
| Founded | 2003 | 2020 |
| Headquarters | Cambridge, United Kingdom | Cambridge, United Kingdom |
| Status | Active | Active |
Size, funding and growth
| Measure | CellCentric | Laverock Therapeutics |
|---|---|---|
| Employees | 53 | Not published |
| Total funding | $375M | $10.0M |
| Latest round | Series D | Seed |
| Valuation | Not published | $1.1B |
| LinkedIn followers | 28,695 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | CellCentric | Laverock Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 60/100 | 41/100 |
| Traction | 57/100 | 35/100 |
| Team | 60/100 | Not published |
| Search visibility | 44/100 | 3/100 |
| Quality | 68/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (32/100) | F (29/100) |
| Domain ratingLink authority, 0-100 | 35/100 | 21/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | CellCentric | Laverock Therapeutics |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | WordPress | Webflow |
| Frameworks | Jquery | Not detected |
| Analytics | Google Analytics 4 | Google Tag Manager |
CellCentric vs Laverock Therapeutics: common questions
Which is better, CellCentric or Laverock Therapeutics?
On our 0-100 score CellCentric rates higher (60/100 against 41/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do CellCentric and Laverock Therapeutics compare on the numbers?
CellCentric leads on our overall score (60/100 against 41/100), domain rating (35/100 against 21/100), funding raised ($375M against $10.0M).
Read the full CellCentric review and pricing or the Laverock Therapeutics review and pricing. You can also browse other CellCentric alternatives we track.